WO2003007960A1 - Procede de protection de la peau humaine contre les infections et traitement externe destine a sa mise en oeuvre - Google Patents

Procede de protection de la peau humaine contre les infections et traitement externe destine a sa mise en oeuvre Download PDF

Info

Publication number
WO2003007960A1
WO2003007960A1 PCT/RU2002/000116 RU0200116W WO03007960A1 WO 2003007960 A1 WO2003007960 A1 WO 2003007960A1 RU 0200116 W RU0200116 W RU 0200116W WO 03007960 A1 WO03007960 A1 WO 03007960A1
Authority
WO
WIPO (PCT)
Prior art keywords
skin
dermatic
protecting
dioxidine
microflora
Prior art date
Application number
PCT/RU2002/000116
Other languages
English (en)
Russian (ru)
Inventor
Vyacheslav Vitalievich Barbinov
Roman Arikovich Grashin
Aleksey Viktorovich Samtsov
Vladimir Nikolaevich Atamanchuk
Vyacheslav Anatolievich Jurieshev
Sergey Dmitrievich Tsiembalov
Sergey Ivanovich Petrov
Andrey Valerievich Babkin
Original Assignee
Muratov, Igor Aleksandrovich
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from RU2001119668/14A external-priority patent/RU2001119668A/ru
Application filed by Muratov, Igor Aleksandrovich filed Critical Muratov, Igor Aleksandrovich
Publication of WO2003007960A1 publication Critical patent/WO2003007960A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings

Definitions

  • the invention is available in the field of medicine and may be used.
  • the left hand side of the distributor is ethanol ( ⁇ , 2014085).
  • antibacterial device as a rule, it is used 1 -
  • SIGNIFICANT FOX (DR. 26) In general, a single, simultaneous application of the drug is available at the place
  • the method of protecting the human being from infection is known, including
  • the objective of the invention is to increase the efficiency
  • SIGNIFICANT FOX (DR. 26) The task posed is solved due to the fact that there is a way to protect the human being from infection, which is concluded in the use of
  • an antimicrobial preparation is used from the chynoxaline group.
  • the consumer is using the required volume of waste.
  • dioxidine may be used
  • chinoksidin may be used as a part of an antimicrobial preparation.
  • - antimicrobial can be introduced in quantities of 0.01 - 10.0 wt.%.
  • liposomal form and in the substitute, ⁇ . e. less than for
  • drugs for example, dioxidine
  • the main external device is short-lived and does not accelerate the external
  • the property declared is also that the antimicrobial is used in small substrates, which are mini
  • the invention may be practiced using

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention appartient au domaine de la médecine et peut s'utiliser pour protéger l'humain contre les infections virales ou bactériennes. On introduit dans un produit à usage externe tel que le savon, le shampooing, le gel ou la crème des préparations anti-infections telles que la dioxydine sous forme liposomale et dans un dosage sous-thérapeutique, par exemple, entre 0,01 et 10 en % en poids. Dans les conditions aérobies des surfaces de la couche cornée de la peau, le produit à usage externe demeure insuffisamment de temps pour influer négativement sur leur microflore extérieure; ses restes sont rapidement rincés de la surface de la peau. La masse principale du produit à usage externe sous forme liposomale pénètrent rapidement dans l'épiderme; là, dans des conditions anaérobies, l'effet bactéricide de la dioxydine est de 10 à 30 fois supérieur, ce qui permet un effet prolongé et efficace au maximum sur la microflore dans l'épaisseur de la peau et de ses annexes en les protégeant ainsi contre toute processus pyogène et inflammatoire venant de l'intérieur. L'invention vise à augmenter l'efficacité des produits antibactériens et à réduire en même temps leur effet négatif sur la microflore utile résidante de la peau.
PCT/RU2002/000116 2001-07-16 2002-03-13 Procede de protection de la peau humaine contre les infections et traitement externe destine a sa mise en oeuvre WO2003007960A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2001119668 2001-07-16
RU2001119668/14A RU2001119668A (ru) 2001-07-16 Способ защиты кожи человека от инфекций и наружное средство для его реализации

Publications (1)

Publication Number Publication Date
WO2003007960A1 true WO2003007960A1 (fr) 2003-01-30

Family

ID=20251729

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RU2002/000116 WO2003007960A1 (fr) 2001-07-16 2002-03-13 Procede de protection de la peau humaine contre les infections et traitement externe destine a sa mise en oeuvre

Country Status (1)

Country Link
WO (1) WO2003007960A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1524951B1 (fr) * 2002-08-02 2012-02-01 C.R.Bard, Inc. Prothese implantable
RU2667974C2 (ru) * 2016-10-11 2018-09-25 Закрытое Акционерное Общество "Биологические Исследования И Системы" (Зао "Бис") Фармацевтическая комбинированная композиция для местного и наружного применения на основе диоксидина

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU94006956A (ru) * 1994-02-28 1997-03-27 Всероссийский научно-исследовательский институт ветеринарной санитарии Антисептическое средство для наружной обработки вымени сельскохозяйственных животных
RU2091020C1 (ru) * 1995-05-30 1997-09-27 Владимир Дмитриевич Соколов Мазь для лечения грибковых и клещевых поражений кожи животного "акаробор"
RU2098129C1 (ru) * 1991-12-27 1997-12-10 Владивостокский государственный медицинский институт Способ лечения кожных заболеваний, сопровождающихся пиодермией

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2098129C1 (ru) * 1991-12-27 1997-12-10 Владивостокский государственный медицинский институт Способ лечения кожных заболеваний, сопровождающихся пиодермией
RU94006956A (ru) * 1994-02-28 1997-03-27 Всероссийский научно-исследовательский институт ветеринарной санитарии Антисептическое средство для наружной обработки вымени сельскохозяйственных животных
RU2091020C1 (ru) * 1995-05-30 1997-09-27 Владимир Дмитриевич Соколов Мазь для лечения грибковых и клещевых поражений кожи животного "акаробор"

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MASHKOVSKY M.D.: "Lekarstvennye sredstva", M, MEDITSINA, vol. 2, 1993, pages 356 - 357 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1524951B1 (fr) * 2002-08-02 2012-02-01 C.R.Bard, Inc. Prothese implantable
RU2667974C2 (ru) * 2016-10-11 2018-09-25 Закрытое Акционерное Общество "Биологические Исследования И Системы" (Зао "Бис") Фармацевтическая комбинированная композиция для местного и наружного применения на основе диоксидина

Similar Documents

Publication Publication Date Title
Naik et al. Suppl-1, M7: Ozone-A Biological Therapy in Dentistry-Reality or Myth?????
Saini Ozone therapy in dentistry: A strategic review
Srikanth et al. Application of ozone in the treatment of periodontal disease
US6034133A (en) Use of a virucidal hand lotion to prevent the spread of rhinovirus colds
Mohammadi et al. A review of the properties and applications of ozone in endodontics: an update
RU2012149863A (ru) Полисахарид семени тамаринда для применения в лечении микробных инфекций
CN105431154A (zh) 抗菌成分
EP3107612A1 (fr) Procédé de maintien de cathéters urétraux
Sheth et al. Pityriasis capitis: Causes, pathophysiology, current modalities, and future approach
US6589568B2 (en) Therapeutic body lotion containing alkali metal hypohalite
JP3253982B2 (ja) にきび用化粧料
WO2003007960A1 (fr) Procede de protection de la peau humaine contre les infections et traitement externe destine a sa mise en oeuvre
WANSKER Antibiotics and pustulocystic acne: A long-term, double-blind evaluation
Ive An overview of experience with ketoconazole shampoo
US10159704B2 (en) Penetrating carrier, anti-fungal composition using the same and method for treatment of dermatophytes
Schauf et al. Cooperative effect of certain anaesthetics on the lobster giant axon
AU657317B2 (en) Use of benzimidazole anthelmintic in the treatment of microsporidial infections
JPS61500844A (ja) シラミの防除方法および防除用組成物
WO1983000628A1 (fr) Procede de traitement de l'acne vulgaire et composition contenant du peroxyde de carbamide
JP3488374B2 (ja) 外用抗感染症助剤
US20020114850A1 (en) Therapeutic bath solution containing alkali metal hypohalite
Sallustio et al. Ozone Therapy in Wound Care
McGregor et al. Further studies on the control of bancroftian filariasis in West Africa by means of diethylcarbamazine
Altman The New Oxygen Prescription: The Miracle of Oxidative Therapies
JPH0454126A (ja) 治療液及びその治療液を含有するサニタリー製品

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BA BG BR CA CN CZ EE GE HR HU ID IL IN JP KP LT LV MK MX NO PL RO SG SI SK TR UA US UZ VN YU

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

Kind code of ref document: A1

Designated state(s): BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP